1Ethier J,Mendelssohn DC,Elder SJ,et al.Vascular access use andoutcomes:an international perspective from the Dialysis Outcomesand Practice Patterns Study[J].Nephrol Dial Transplant,2008,23(10):3219-3226.
8Svoboda P,Barton RP,Barbarash OL.et al.Recombinant urokinase is safe and effective in restoring patency to occluded central venous access devices:a multiple-center,international trial[J].Crit Care Med,2004,32:1990-1996.
9Twardowski ZJ.High-dose intradialytic urokinase to restore the patency of permanent central vein hemodialy-sis catheters[J].Am J Kidney Dis,1998,31:841-847.
10Meers C,Toffelmire EB.Urokinase efficacy in the resto-ration of hemodialysis catheter function[J].J CANNT,1998,8:17-19.
2Schwab S,Buller G,Mccann R. Prospective evaluation of a dacron cuffed hemodialysis catheter for prolonged use[J].American Journal of Kidney Diseases,1988,(02):166-169.
3Alomari A I,Falk A. The natural history of tunneled hemodialysis catheters removed or exchanged:a single-institution experience[J].Journal of Vascular and Interventional Radiology,2007,(02):227-235.doi:10.1016/j.jvir.2006.12.719.
4Lok C E,Mokrzycki M H. Prevention and management of cathete-related infection in hemodialysis patients[J].Kidney International,2011,(06):587-598.
6Hassan H,Frenchie D,Bastani B. Effect of reversal of catheter ports on recirculation:comparison of the Perm Cath with Tesio Twin Catheter[J].ASAIO Journal,2002,(03):316-319.
7Allon M,Fistul A. First:recent progress and ongoing challenges[J].American Journal of Kidney Diseases,2011,(01):3-6.
